510(k) device
DEKA ACE Pump System
Deka Research and Development · Alternate Controller Enabled Insulin Infusion Pump (QFG, Class II) · First FDA decision Jul 25, 2023, newest May 24, 2024Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
0
Naming "DEKA ACE"
MAUDE reports
0
Brand "DEKA ACE", since 2015
PubMed studies
0
Mentioning "DEKA ACE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DEKA ACE Pump System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- DEKA ACE Pump System510(k)
K241178 · Decided May 24, 2024 · 25 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
- DEKA ACE Pump System510(k)
K233952 · Decided Mar 13, 2024 · 89 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
- DEKA ACE Pump System510(k)
K213536 · Decided Jul 25, 2023 · 627 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Insulin Infusion PumpNational analysisReview closedCAG-00041NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "DEKA ACE", any status and sponsor, newest update first.
No registered device study names "DEKA ACE".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DEKA ACE", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFG
1,370,384 reports: 1,216,047 malfunction, 153,806 injury, 383 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DEKA ACE"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QFG.
- Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 510(k) 2025
- t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc. · De Novo 2025
- iLet ACE PumpBeta Bionics, Inc. · 510(k) 2026
- Mint ACE PumpBeta Bionics, Inc. · 510(k) 2026
- MiniMed 780G Insulin Pump (MMT-1884)Medtronic Minimed, Inc. · 510(k) 2026
- Omnipod 5 ACE PumpInsulet Corporation · 510(k) 2023
- twiist Automated Insulin Delivery (AID) SystemDeka Research and Development · 510(k) 2026
- MiniMed Flex pumpMedtronic Minimed, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.